Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Blocking BMP signaling causes hair loss and disrupts hair growth cycles.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Some birth control pills have a higher risk of blood clots than others.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

Citrullus colocynthis has pain-relieving, anti-inflammatory, antidiabetic, and hair growth benefits, but can cause side effects like colic and diarrhea.

Frequent use of chemical hair relaxants is linked to increased scarring hair loss in Nigerian women.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

HIV can cause various severe or unusual skin conditions that help indicate the presence and stage of the disease.

Syphilis can cause hair loss that looks like other conditions, but it improves with treatment.

HIV can cause unusual and severe skin problems that are hard to treat.

The document suggests a possible link between Crohn's disease and Johne's disease and calls for more research.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Minoxidil helps some bald men, but most lose hair again when stopping.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.